Question 1

Purpose of the Test

Accepted Answer

Differentiate between benign hyperplasia and early-stage cancer. Determine the most appropriate treatment strategy based on genetic findings. Monitor high-risk patients susceptible to gynecological tumors.

Question 2

Target Groups

Accepted Answer

Women diagnosed with atypical endometrial hyperplasia. Patients suspected of having early-stage endometrial cancer. Individuals with a family history of genetic tumor syndromes.

Question 3

Frequently Asked Questions

Accepted Answer

Does the test require blood or tissue? It is typically performed on a tissue biopsy as requested by the physician. How long do results take? Results are usually available within 7 to 10 working days.

Secure Your Uterine Health - PTEN Gene Mutation Analysis for Endometrial Tumors